Nerve Degeneration: all 147 studies
Page 2 of 2. Open to participants first (55), then studies with results posted, then the rest; newest registration first within each.
- Perioperative Adverse Cardiovascular Event in Type-2 Diabetic PatientsStatus unknownNCT04579406
- The Energetic Origin of Neurodegeneration in MSCompletedNCT04532944Not applicable
- Preventing Cognitive Decline with MetforminActive, not recruitingNCT04511416Phase 3
- Effects of tDCS on Apraxia of Speech in Non-Fluent Primary Progressive AphasiaWithdrawnNCT04486586Not applicable
- Safety, Tolerability and Pharmacokinetics of Inhaled Nanoparticle Formulation of Remdesivir (GS-5734) and NA-831Status unknownNCT04480333Phase 1
- Visualising Cerebral and Peripheral Cholinergic Nerves in Patients With Dementia Lewy Bodies.CompletedNCT04291144
- Acute Effects of Vigorous-intensity Aerobic Exercise on Glymphatic Flow in Healthy AdultsStatus unknownNCT04255758Not applicable
- Partnered Dance Aerobic Exercise as a Neuroprotective, Motor and Cognitive Intervention in Parkinson's DiseaseActive, not recruitingNCT04122690Not applicable
- Search for Biomarkers of Neurodegenerative Diseases in Idiopathic REM Sleep Behavior DisorderStatus unknownNCT04048603
- MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI PatientsCompletedNCT04032626Phase 2
- 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Multiple Sclerosis.CompletedNCT03993171Phase 2
- 31P-MRS Imaging to Assess the Effects of CNM-Au8 on Impaired Neuronal Redox State in Amyotrophic Lateral Sclerosis (REPAIR-ALS)WithdrawnNCT03843710Phase 2
- Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)Active, not recruitingNCT03775096Phase 2
- Add-on Low Dose Dextromethorphan and Memantine in Patients With Amphetamine-type Stimulants Use DisorderCompletedNCT03729128Phase 1/2
- Anesthetic Method and Cerebral OutcomesStatus unknownNCT03696719Not applicable
- Progression of Prodromal Markers of α-synucleinopathy Neurodegeneration in the FDRs of Patients With RBDCompletedNCT03671772
- Evaluation of a Novel PET Radioligand to Image OGACompletedNCT03632226
- Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK)CompletedNCT03430869Phase 2
- Central and Peripheral Nervous System Changes as Markers of Disease Progression in Multiple SclerosisCompletedNCT03401307
- Striatal Dopamine Transmission in Individuals With Isolated Rapid Eye Movement Sleep With Atonia: a Search for Precursor Biomarker for NeurodegenerationCompletedNCT03353207
- A Phase I [18F]THK-5351 Positron Emission Tomography Study in Healthy Subjects and Alzheimer's DiseaseCompletedNCT03112096Phase 1
- More Than a Movement Disorder: Applying Palliative Care to Parkinson's DiseaseCompletedNCT03076671Not applicable
- Neurodegeneration in Newborns After AnestheticsCompletedNCT03064607
- Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem CellsCompletedNCT02983708Phase 1/2
- Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for DepressionCompletedNCT02661789Not applicable
- [18F]THK-5351 Positron Emission Computed Tomography Study of Normal, Mild Cognitive Impairment, Alzheimer's Disease and Other Neurodegenerative DiseaseCompletedNCT02656498Phase 2
- Mitochondrial Dysfunction and Disease ProgressionCompletedNCT02549703
- GM604 Phase 2A Randomized Double-blind Placebo Controlled Pilot Trial in Amyotrophic Lateral Disease (ALS)CompletedNCT01854294Phase 2
- Assessment of Bone Marrow-derived Cellular Therapy in Progressive Multiple Sclerosis (ACTiMuS)Status unknownNCT01815632Phase 2
- Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in Patients With Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01777646Phase 2
- Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 DiseaseCompletedNCT01747135Phase 1
- Prognosis Value of the Neuronal Damage in Early Multiple SclerosisStatus unknownNCT01651520Not applicable
- A Pilot Trial to Test the Feasibility of Prolonged Fasting and Ketogenic Diet in Relapsing-remitting Multiple SclerosisCompletedNCT01538355Not applicable
- EEG Objectification in NeuropsychiatryStatus unknownNCT01476228Not applicable
- Effects of Cocoa Flavanols on Human Cognitive FunctionCompletedNCT01344551Not applicable
- Orange Juice Consumption and Cognitive FunctionCompletedNCT01312610Not applicable
- Effects of Flavonoids on Cognitive Performance in Healthy Young AdultsCompletedNCT01312597Phase 2
- Serial Electrophysiologic Monitoring During Administration of Nerve-Toxic Chemotherapeutic DrugsStatus unknownNCT01208545
- Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)CompletedNCT01181310Phase 1
- Autologous Cultured Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors (MSC-NTF), in ALS Patients.CompletedNCT01051882Phase 1/2
- Evaluation of Nerve Regeneration After Nerve Transsection Using (Diffusion-tensor Magnetic Resonance Imaging) DTI MR ImagingCompletedNCT01020149
- Ferrochelating Treatment in Patients Affected by Neurodegeneration With Brain Iron Accumulation (NBIA)Status unknownNCT00907283Phase 2
- Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper DeficiencyCompletedNCT00811785Phase 3
- Sunphenon Epigallocatechin-gallate (EGCg) in Relapsing-remitting Multiple Sclerosis (SuniMS Study)CompletedNCT00525668Phase 1/2
- Measures of Motor Impairment in Early Parkinson's DiseaseCompletedNCT00291265
- Phase 1 Trial of Idebenone to Treat Patients With Friedreich's AtaxiaCompletedNCT00078481Phase 1
- Safety Study of Idebenone to Treat Friedreich's AtaxiaCompletedNCT00015808Phase 1